---
title: "Dhansa Labs Ltd (DHANSA) — Share Price, Financials & Analysis"
symbol: "DHANSA"
company: "Dhansa Labs Ltd"
canonical: "https://tapetide.com/stocks/DHANSA"
nse_symbol: "DHANSA"
sector: "Commodities"
industry: "Fertilizers & Agrochemicals"
generated_at: "2026-09-13T18:34:45.464Z"
---

# Dhansa Labs Ltd (DHANSA)

Canonical page: https://tapetide.com/stocks/DHANSA

## Company

- **NSE Symbol:** DHANSA
- **Sector:** Commodities
- **Industry:** Fertilizers & Agrochemicals
- **Macro Sector:** Commodities
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** dhansalabs.com

## About

Incorporated in 1985, Ambey Laboratories Ltd is in the business of manufacturing and distribution of agro and home hygiene products.[1]

## Latest Price

- **Price:** ₹35.75
- **Change:** +1.7 (+4.99%)
- **Open:** ₹35.45
- **Day High:** ₹35.75
- **Day Low:** ₹35.45
- **Previous Close:** ₹34.05
- **Volume:** 26000
- **As Of:** 2026-09-11T09:31:29+00:00

## Key Insights

### Strengths

- Stock is trading at 0.90 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -5.10%
- The company has delivered a poor sales growth of 11.6% over past five years.
- Company has a low return on equity of 11.0% over last 3 years.
- Company might be capitalizing the interest cost
- Debtor days have increased from 103 to 139 days.
- Working capital days have increased from 115 days to 169 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 23% | 3% | -11% |
| revenue growth | 8% | 11% | 12% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 30.55 | 28.29 | 32.82 | 40.54 | 30.56 |
| Expenses | 28.2 | 25.42 | 30.13 | 38.21 | 27.9 |
| Operating Profit | 2.35 | 2.87 | 2.69 | 2.33 | 2.66 |
| OPM % | 7.69 | 10.14 | 8.2 | 5.75 | 8.7 |
| Other Income | 0.86 | 0.02 | 0.3 | 1.08 | 0.63 |
| Interest | 1 | 1 | 0.32 | 0.38 | 0.71 |
| Depreciation | 0.67 | 0.55 | 0.55 | 0.54 | 0.44 |
| Profit before tax | 1.54 | 1.34 | 2.12 | 2.49 | 2.14 |
| Tax % | 24.68 | 10.45 | 51.42 | 16.06 | 37.38 |
| Net Profit | 1.17 | 1.2 | 1.02 | 2.09 | 1.34 |
| EPS in Rs | 0.47 | 0.48 | 0.41 | 0.84 | 0.5 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 82 | 85 | 105 | 120 | 131 | 142 |
| Expenses | 72 | 74 | 97 | 111 | 122 | 131 |
| Operating Profit | 10 | 10 | 8 | 9 | 10 | 11 |
| OPM % | 12 | 12 | 7 | 8 | 7 | 8 |
| Other Income | 1 | 1 | 3 | 1 | 2 | 2 |
| Interest | 4 | 3 | 2 | 2 | 3 | 3 |
| Depreciation | 3 | 3 | 3 | 2 | 3 | 2 |
| Profit before tax | 3 | 5 | 6 | 6 | 6 | 8 |
| Tax % | -235 | 26 | 5 | -40 | 21 | 25 |
| Net Profit | 10 | 4 | 5 | 8 | 5 | 6 |
| EPS in Rs | 211.28 | 20.11 | 29.52 | 4.13 | 1.92 | 2.3 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 5 | 18 | 18 | 19 | 25 | 25 |
| Reserves | -13 | 1 | 1 | 13 | 51 | 74 |
| Borrowings | 33 | 18 | 14 | 30 | 41 | 40 |
| Other Liabilities | 20 | 19 | 21 | 18 | 10 | 11 |
| Total Liabilities | 45 | 56 | 54 | 79 | 127 | 149 |
| Fixed Assets | 16 | 25 | 25 | 24 | 23 | 21 |
| CWIP | 1 | 0 | 0 | 4 | 16 | 22 |
| Investments | 0 | 0 | 1 | 1 | 0 | 0 |
| Other Assets | 28 | 31 | 28 | 51 | 88 | 106 |
| Total Assets | 45 | 56 | 54 | 79 | 127 | 149 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 3 | 6 | 10 | -13 | -34 | -1 |
| Cash from Investing Activity | -1 | -1 | -4 | -5 | -14 | -11 |
| Cash from Financing Activity | -1 | -5 | -6 | 18 | 48 | 13 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 1 |
| Free Cash Flow | 2 | 5 | 7 | -18 | -48 | -7 |
| CFO/OP | 23 | 47 | 120 | -131 | -347 | 0 |

### Ratios

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 31 | 37 | 12 | 57 | 112 | 139 |
| Inventory Days | — | — | 78 | 75 | 99 | 95 |
| Days Payable | — | — | 74 | 54 | 22 | 19 |
| Cash Conversion Cycle | 31 | 37 | 17 | 78 | 189 | 215 |
| Working Capital Days | -10 | 11 | 18 | 49 | 126 | 169 |
| ROCE % | — | 25 | 22 | 18 | 10 | 8 |

## Shareholding Pattern

### annual

| Category | Mar 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- |
| Promoters | 70.11% | 70.15% | 65.05% |
| FIIs | 0.01% | 0% | 0% |
| DIIs | 2.34% | 0.72% | 0% |
| Public | 27.54% | 29.13% | 34.95% |
| No. of Shareholders | 1327 | 1224 | 1201 |

### Quarterly

| Category | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 69.9% | 70.11% | 70.15% | 70.15% | 65.05% |
| FIIs | 1.46% | 0.01% | 0% | 0% | 0% |
| DIIs | 4.11% | 2.34% | 1.96% | 0.72% | 0% |
| Public | 24.53% | 27.54% | 27.89% | 29.13% | 34.95% |
| No. of Shareholders | 1520 | 1327 | 1291 | 1224 | 1201 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 1 / 5

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 29.78 | Buy |
| EMA (10) | 30.38 | Buy |
| SMA (20) | 26.1 | Buy |
| EMA (20) | 27.52 | Buy |
| SMA (50) | 23.35 | Buy |
| EMA (50) | 25 | Buy |
| SMA (100) | 24.47 | Buy |
| EMA (100) | 25.53 | Buy |
| SMA (200) | 29.65 | Buy |
| EMA (200) | 29.53 | Buy |

### Oscillators — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 84.02 | Sell |
| MACD (12,26,9) | 3.09 | Buy |
| Stochastic (14,3,3) | 100 | Sell |
| ADX (14) | 43.35 | Buy |
| Williams %R (14) | 0 | Sell |
| ATR (14) | 1.33 | High Volatility |
| ROC (12) | 51.16 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 92.61 | Sell |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Jul - Submitted Regulation 74(5) compliance certificate for quarter ended 30 June 2026; no demat requests received. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 9 Jul - Submitted Regulation 74(5) compliance certificate for quarter ended 30 June 2026; no demat requests received.](https://nsearchives.nseindia.com/corporate/AMBEY_09072026194122_Complaince_Certificate_74_5__of_the_SEBI__DP__Regulations_2018_signed.pdf) |
| 7 Aug - Board approved object clause change, asset charge, and material RPT; postal ballot on August 7, 2026. | [Outcome of Board Meeting 7 Aug - Board approved object clause change, asset charge, and material RPT; postal ballot on August 7, 2026.](https://nsearchives.nseindia.com/corporate/AMBEY_07082026185650_Outcome_of_board_meeting.pdf) |
| 6 June 2026 - Audio recording of 5 June 2026 earnings call for Q4 and FY2025-26 results uploaded. | [Analysts/Institutional Investor Meet/Con. Call Updates 6 June 2026 - Audio recording of 5 June 2026 earnings call for Q4 and FY2025-26 results uploaded.](https://nsearchives.nseindia.com/corporate/AMBEY_06062026182336_IntimationEarningscall.pdf) |
| 5 June 2026 - FY26 audited results: revenue ₹141.54 crore, EBITDA ₹12.22 crore, PAT ₹5.52 crore; expansion and CBG projects outlined. | [Investor Presentation 5 June 2026 - FY26 audited results: revenue ₹141.54 crore, EBITDA ₹12.22 crore, PAT ₹5.52 crore; expansion and CBG projects outlined.](https://nsearchives.nseindia.com/corporate/AMBEY_05062026165638_Investor_Presentation.pdf) |
| 4 Sep - 41st AGM on 26 Sep 2026 via VC/OAVM; notice published in Financial Express and Jansatta on 4 Sep 2026. | [Copy of Newspaper Publication 4 Sep - 41st AGM on 26 Sep 2026 via VC/OAVM; notice published in Financial Express and Jansatta on 4 Sep 2026.](https://nsearchives.nseindia.com/corporate/AMBEY_04092026170754_Post_Newspaper_Advertisement.pdf) |
| 31 May 2026 - Newspaper advertisement for Q4, half-year and FY2026 standalone/consolidated financial results published on May 31, 2026. | [Copy of Newspaper Publication 31 May 2026 - Newspaper advertisement for Q4, half-year and FY2026 standalone/consolidated financial results published on May 31, 2026.](https://nsearchives.nseindia.com/corporate/AMBEY_31052026155038_Intimation_for_Newspaper_advt_31052026_signed.pdf) |
| 27 Aug - Board approved 41st AGM notice, Directors’ Report, and scrutinizer appointment on 27 August 2026. | [Outcome of Board Meeting 27 Aug - Board approved 41st AGM notice, Directors’ Report, and scrutinizer appointment on 27 August 2026.](https://nsearchives.nseindia.com/corporate/AMBEY_27082026175404_Outcome_of_BM.pdf) |
| 26 Aug - NSE approved listing of 19,56,521 equity shares from warrant conversion, effective August 26, 2026. | [General Updates 26 Aug - NSE approved listing of 19,56,521 equity shares from warrant conversion, effective August 26, 2026.](https://nsearchives.nseindia.com/corporate/AMBEY_26082026184415_Intimation_Trading_Approval_Preferential_Warrants.pdf) |
| 26 Aug - Groundbreaking held on 26 Aug 2026 for 15 TPD CBG project in Bundi, Rajasthan. | [General Updates 26 Aug - Groundbreaking held on 26 Aug 2026 for 15 TPD CBG project in Bundi, Rajasthan.](https://nsearchives.nseindia.com/corporate/AMBEY_26082026185519_Intimation_under_Regulation_30_Bhoomi_Poojan_signed.pdf) |
| 25 Jun - Trading window closes July 1, 2026 until 48 hours after Q1 FY26 results. | [Trading Window 25 Jun - Trading window closes July 1, 2026 until 48 hours after Q1 FY26 results.](https://nsearchives.nseindia.com/corporate/AMBEY_25062026171654_Intimation_for_closure_of_trading_window.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_31399_DHANSA_2025_2026_A_7675635_04092026171744.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28467_AMBEY_2024_2025_A_4740905_04092025190011.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26178_AMBEY_2023_2024_07092024195044.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:34:45.464Z.